Stephen P. Robertson Net Worth

The estimated Net Worth of Stephen P. Robertson is at least $3.59 millió dollars as of 6 March 2024. Mr Robertson owns over 57,745 units of Aurinia Pharmaceuticals Inc stock worth over $2,898,171 and over the last 4 years he sold AUPH stock worth over $496,826. In addition, he makes $193,430 as Exec. VP, Gen. Counsel és Corp. Sec. & Chief Compliance Officer at Aurinia Pharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Robertson AUPH stock SEC Form 4 insiders trading

Mr has made over 3 trades of the Aurinia Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 57,745 units of AUPH stock worth $323,372 on 6 March 2024.

The largest trade he's ever made was selling 57,745 units of Aurinia Pharmaceuticals Inc stock on 6 March 2024 worth over $323,372. On average, Mr trades about 15,609 units every 227 days since 2021. As of 6 March 2024 he still owns at least 443,824 units of Aurinia Pharmaceuticals Inc stock.

You can see the complete history of Mr Robertson stock trades at the bottom of the page.

Mr. Stephen P. Robertson biography

Stephen P. Robertson is the Exec. VP, Gen. Counsel, Corp. Sec. & Chief Compliance Officer at Aurinia Pharmaceuticals Inc.

What is the salary of Mr Robertson?

As the Exec. VP, Gen. Counsel és Corp. Sec. & Chief Compliance Officer of Aurinia Pharmaceuticals Inc, the total compensation of Mr Robertson at Aurinia Pharmaceuticals Inc is $193,430. There are 13 executives at Aurinia Pharmaceuticals Inc getting paid more, with Peter Greenleaf having the highest compensation of $1,678,600.

How old is Mr Robertson?

Mr Robertson is 39, he's been the Exec. VP, Gen. Counsel és Corp. Sec. & Chief Compliance Officer of Aurinia Pharmaceuticals Inc since . There are 15 older and no younger executives at Aurinia Pharmaceuticals Inc. The oldest executive at Aurinia Pharmaceuticals Inc is George Milne, 76, who is the Independent Chairman of the Board.

What's Mr Robertson's mailing address?

Stephen's mailing address filed with the SEC is #140, 14315 - 118 AVENUE, , EDMONTON, A0, T5L 4S6.

Insiders trading at Aurinia Pharmaceuticals Inc

Over the last 4 years, insiders at Aurinia Pharmaceuticals Inc have traded over $22,019,765 worth of Aurinia Pharmaceuticals Inc stock and bought 107,125 units worth $893,295 . The most active insiders traders include Timothy P Walbert, Michael R Hayden és Michael Robert Martin. On average, Aurinia Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of $193,451. The most recent stock trade was executed by Scott Michael Habig on 6 August 2024, trading 18,249 units of AUPH stock currently worth $96,902.

What does Aurinia Pharmaceuticals Inc do?

aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada.

Complete history of Mr Robertson stock trades at Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc executives and stock owners

Aurinia Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Peter Greenleaf,
  President, Chief Executive Officer, Director
• Peter S. Greenleaf M.B.A.,
  Pres, CEO & Director
• Maxwell Donley,
  Executive Vice President, Internal Operations & Strategy
• Neil Solomons,
  Chief Marketing Officer
• Massimiliano Colao,
  Chief Commercial Officer
• Robert Huizinga,
  Executive Vice President - Corporate Development
• Matthew Maxwell Donley M.B.A.,
  Exec. VP of Operations & Strategy
• Joseph M. Miller CPA,
  Chief Financial Officer
• Dennis Bourgeault,
  Chief Financial Officer
• Michael Martin,
  Chief Operating Officer
• Daniel Billen,
  Director
• George Milne,
  Independent Chairman of the Board
• Michael Hayden,
  Independent Director
• Stephen P. Robertson,
  Exec. VP, Gen. Counsel, Corp. Sec. & Chief Compliance Officer
• Joseph Hagan,
  Independent Director
• David Jayne,
  Independent Director
• R. Hector MacKay-Dunn,
  Director
• Jill Leversage,
  Independent Director
• Stephen Robertson,
  Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
• Timothy Walbert,
  Independent Director
• Max Colao,
  Chief Commercial Officer
• Tim Hermes,
  Vice President of Market Access
• Cara Felish,
  Vice President of Commercial Operations
• Chris Hays,
  Vice President of Marketing
• Fran Lynch,
  Vice President of Sales
• Glenn Schulman,
  Senior Vice President - Corporate Communications and Investor Relations
• Michael R. Martin,
  Chief Bus. Officer
• Dr. Robert B. Huizinga M.Sc., Ph.D., R.N., RN NNC, MSc(Epi), CNeph(C),
  Exec. VP of Research
• Scott Michael Habig,
  Chief Commercial Officer
• Volker Knappertz,
  EVP, Research and Development
• Joseph M Miller,
  Chief Financial Officer
• Brinda Balakrishnan,
  Director
• Robert T Foster,
  Director
• Massimilano Colao,
  Chief Commercial Officer
• Jeffrey Allen Bailey,
  Director
• Karen L. Smith,
  Director